Conference on Endothelin Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease

@inproceedings{Komers2016ConferenceOE,
  title={Conference on Endothelin Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease},
  author={Radko Komers and Horacio Plotkin},
  year={2016}
}
Komers R, Plotkin H. Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease. Am J Physiol Regul Integr Comp Physiol 310: R877–R884, 2016. First published March 23, 2016; doi:10.1152/ajpregu.00425.2015.—Inhibition of the renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in treatment of chronic kidney diseases (CKD). However, reversal of the course of CKD or at least long-term stabilization of renal function are often… CONTINUE READING